Comparison of Two Therapeutic Strategies for Treating Type 2 Diabetic Patients Poorly Controlled With Basal Insulin Associated With Oral Antidiabetic Drugs : 6-Month Proof of Concept Study.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Insulin glulisine (Primary) ; Glimepiride; Insulin glargine; Metformin
Indications Type 2 diabetes mellitus
Focus Proof of concept; Therapeutic Use
Sponsors Sanofi

01 Nov 2011 Results published in the Diabetes, Obesity and Metabolism.
03 Feb 2010 Patient numbers amended from 135 to 106 as reported by ClinicalTrials.gov.
05 Jun 2009 Status changed from active, no longer recruiting to completed, according to results presented at the 69th Annual Scientific Sessions of the American Diabetes Association.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com